Bidirectional Two-sample Mendelian Randomization Analysis Identifies Causal Associations of MRI-based Cortical Thickness and Surface Area Relation to NAFLD

Overview

Journal Lipids Health Dis

Publisher Biomed Central

Specialties Biochemistry
Endocrinology

Date 2024 Feb 23

PMID 38395962

Authors

Zun Mao

Zhi-Xiang Gao

Tong Ji

Sheng Huan

Guo-Ping Yin

Long Chen

Affiliations

Soon will be listed here.

Abstract

Background: Non-alcoholic fatty liver disease (NAFLD) patients have exhibited extra-hepatic neurological changes, but the causes and mechanisms remain unclear. This study investigates the causal effect of NAFLD on cortical structure through bidirectional two-sample Mendelian randomization analysis.

Methods: Genetic data from 778,614 European individuals across four NAFLD studies were used to determine genetically predicted NAFLD. Abdominal MRI scans from 32,860 UK Biobank participants were utilized to evaluate genetically predicted liver fat and volume. Data from the ENIGMA Consortium, comprising 51,665 patients, were used to evaluate the associations between genetic susceptibility, NAFLD risk, liver fat, liver volume, and alterations in cortical thickness (TH) and surface area (SA). Inverse-variance weighted (IVW) estimation, Cochran Q, and MR-Egger were employed to assess heterogeneity and pleiotropy.

Results: Overall, NAFLD did not significantly affect cortical SA or TH. However, potential associations were noted under global weighting, relating heightened NAFLD risk to reduced parahippocampal SA and decreased cortical TH in the caudal middle frontal, cuneus, lingual, and parstriangularis regions. Liver fat and volume also influenced the cortical structure of certain regions, although no Bonferroni-adjusted p-values reached significance. Two-step MR analysis revealed that liver fat, AST, and LDL levels mediated the impact of NAFLD on cortical structure. Multivariable MR analysis suggested that the impact of NAFLD on the cortical TH of lingual and parstriangularis was independent of BMI, obesity, hyperlipidemia, and diabetes.

Conclusion: This study provides evidence that NAFLD causally influences the cortical structure of the brain, suggesting the existence of a liver-brain axis in the development of NAFLD.

References

Chen H, Zhu X, Jiao Y, Li P, Wang Y, Teng G . Abnormal baseline brain activity in low-grade hepatic encephalopathy: a resting-state fMRI study. J Neurol Sci. 2012; 318(1-2):140-5. DOI: 10.1016/j.jns.2012.02.019. View

Sanderson E, Davey Smith G, Windmeijer F, Bowden J . An examination of multivariable Mendelian randomization in the single-sample and two-sample summary data settings. Int J Epidemiol. 2018; 48(3):713-727. PMC: 6734942. DOI: 10.1093/ije/dyy262. View

Salamon G, Salamon N, Johnson N, Mongkolwat P, Gitelman D, Weintraub S . [Magnetic resonance studies in Alzheimer's dementia. What routine scanning shows]. Rev Neurol (Paris). 2004; 160(1):63-73. DOI: 10.1016/s0035-3787(04)70848-6. View

McCarley R, Shenton M, ODonnell B, Nestor P . Uniting Kraepelin and Bleuler: the psychology of schizophrenia and the biology of temporal lobe abnormalities. Harv Rev Psychiatry. 1993; 1(1):36-56. DOI: 10.3109/10673229309017055. View

Iwasa M, Matsumura K, Watanabe Y, Yamamoto M, Kaito M, Ikoma J . Improvement of regional cerebral blood flow after treatment with branched-chain amino acid solutions in patients with cirrhosis. Eur J Gastroenterol Hepatol. 2003; 15(7):733-7. DOI: 10.1097/01.meg.0000059162.46867.f0. View

Hemani G, Tilling K, Davey Smith G . Orienting the causal relationship between imprecisely measured traits using GWAS summary data. PLoS Genet. 2017; 13(11):e1007081. PMC: 5711033. DOI: 10.1371/journal.pgen.1007081. View

Heeren M, Weissenborn K, Arvanitis D, Bokemeyer M, Goldbecker A, Tountopoulou A . Cerebral glucose utilisation in hepatitis C virus infection-associated encephalopathy. J Cereb Blood Flow Metab. 2011; 31(11):2199-208. PMC: 3210344. DOI: 10.1038/jcbfm.2011.82. View

Bowden J, Del Greco M F, Minelli C, Davey Smith G, Sheehan N, Thompson J . A framework for the investigation of pleiotropy in two-sample summary data Mendelian randomization. Stat Med. 2017; 36(11):1783-1802. PMC: 5434863. DOI: 10.1002/sim.7221. View

Starekova J, Hernando D, Pickhardt P, Reeder S . Quantification of Liver Fat Content with CT and MRI: State of the Art. Radiology. 2021; 301(2):250-262. PMC: 8574059. DOI: 10.1148/radiol.2021204288. View

10.

Bowden J, Davey Smith G, Haycock P, Burgess S . Consistent Estimation in Mendelian Randomization with Some Invalid Instruments Using a Weighted Median Estimator. Genet Epidemiol. 2016; 40(4):304-14. PMC: 4849733. DOI: 10.1002/gepi.21965. View

11.

Beller E, Lorbeer R, Keeser D, Schoeppe F, Sellner S, Hetterich H . Hepatic fat is superior to BMI, visceral and pancreatic fat as a potential risk biomarker for neurodegenerative disease. Eur Radiol. 2019; 29(12):6662-6670. DOI: 10.1007/s00330-019-06276-8. View

12.

Teslovich T, Kim D, Yin X, Stancakova A, Jackson A, Wielscher M . Identification of seven novel loci associated with amino acid levels using single-variant and gene-based tests in 8545 Finnish men from the METSIM study. Hum Mol Genet. 2018; 27(9):1664-1674. PMC: 5905595. DOI: 10.1093/hmg/ddy067. View

13.

Chen X, Kong J, Pan J, Huang K, Zhou W, Diao X . Kidney damage causally affects the brain cortical structure: A Mendelian randomization study. EBioMedicine. 2021; 72:103592. PMC: 8498227. DOI: 10.1016/j.ebiom.2021.103592. View

14.

Hadjihambi A, Konstantinou C, Klohs J, Monsorno K, Le Guennec A, Donnelly C . Partial MCT1 invalidation protects against diet-induced non-alcoholic fatty liver disease and the associated brain dysfunction. J Hepatol. 2022; 78(1):180-190. DOI: 10.1016/j.jhep.2022.08.008. View

15.

Cheng Y, Zhang G, Shen W, Huang L, Zhang L, Xie S . Impact of previous episodes of hepatic encephalopathy on short-term brain function recovery after liver transplantation: a functional connectivity strength study. Metab Brain Dis. 2017; 33(1):237-249. DOI: 10.1007/s11011-017-0155-5. View

16.

Chen J, Liu S, Wang C, Zhang C, Cai H, Zhang M . Associations of Serum Liver Function Markers With Brain Structure, Function, and Perfusion in Healthy Young Adults. Front Neurol. 2021; 12:606094. PMC: 7947675. DOI: 10.3389/fneur.2021.606094. View

17.

Vegas-Suarez S, Simon J, Martinez-Chantar M, Moratalla R . Metabolic Diffusion in Neuropathologies: The Relevance of Brain-Liver Axis. Front Physiol. 2022; 13:864263. PMC: 9134112. DOI: 10.3389/fphys.2022.864263. View

18.

Prell T, Dirks M, Arvanitis D, Braun D, Peschel T, Worthmann H . Cerebral patterns of neuropsychological disturbances in hepatitis C patients. J Neurovirol. 2019; 25(2):229-238. DOI: 10.1007/s13365-018-0709-2. View

19.

Eslam M, Valenti L, Romeo S . Genetics and epigenetics of NAFLD and NASH: Clinical impact. J Hepatol. 2017; 68(2):268-279. DOI: 10.1016/j.jhep.2017.09.003. View

20.

Nucera S, Ruga S, Cardamone A, Coppoletta A, Guarnieri L, Zito M . MAFLD progression contributes to altered thalamus metabolism and brain structure. Sci Rep. 2022; 12(1):1207. PMC: 8786899. DOI: 10.1038/s41598-022-05228-5. View